Tianjin Medical University General Hospital
Tianjin, 300000, China
Location status: Recruiting
Location contact
Dan Liu
CONTACT
Dan Liu
PRINCIPAL_INVESTIGATOR
Jing Feng
CONTACT
NCT Number: NCT06128681
The goal of this observational study is to learn whether patients undergoing mediastinal disease diagnosis and combined treatment with intrapacial ultrasound-guided mediastinal opening techniques have greater clinical benefit.
The main questions it aims to answer are:
* Whether the mediastinal ultrasound-guided mediastinal opening technique is more beneficial for the diagnosis of benign or malignant mediastinal diseases. * Does the mediastinal ultrasound-guided mediastinal opening technique benefit the patient by ablating mediastinal masses using freezing, laser, or other means.
Mediastinal diseases were diagnosed by lymph node biopsy combined with NGS, ROSE and other techniques using transairway ultrasound-guided mediastinal opening technique. Ablation of mediastinal malignancies is performed using techniques such as freezing or laser. Transbronchial lung biopsy(TBLB) may also be performed when necessary. Researchers will compare the experimental group with mediastinal opening and the control group without mediastinal opening to see if Mediastinal open technique benefits patients.
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
Tianjin, 300000, China
Location status: Recruiting
Dan Liu
CONTACT
Dan Liu
PRINCIPAL_INVESTIGATOR
Jing Feng
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mediastinal intervention for patients with mediastinal imaging abnormalities is performed under general anesthesia to obtain biopsy specimens for detection or elimination of mediastinal masses
A standardized supplementary procedure performed in all patients with active pulmonary sarcoidosis and fibrosing mediastinitis, regardless of their primary study group assignment, to obtain lung tissue for histopathological diagnosis and disease activity assessment.
Time frame: 11 months
The contribution of pathological results to the final diagnosis of the disease between the experimental group and the control group was observed.That is, the difference in diagnostic accuracy between the experimental group and the control group.
Time frame: 11 months
Time frame: 11 months
Time frame: 11 months
Time frame: 11 months
Time frame: At the time of biopsy and sample collection
Single-cell RNA sequencing will be performed on blood, bronchoalveolar lavage fluid (BALF), transbronchial needle biopsy (TBNB) and transbronchial lung biopsy (TBLB) tissue samples to characterize immune cell profiles, identify pathogenic mechanisms, and discover potential therapeutic targets in patients with active pulmonary sarcoidosis.
Dan Liu
Other
Application Value of Respiratory Mediastinal Intervention Technique in Diagnosis and Comprehensive Treatment of Diseases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05694806
Mediastinal Diseases, Respiratory Tract Diseases
Toulouse, France
View Trial DetailsNCT05374447
Hemic and Lymphatic Diseases, Hypersensitivity
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06793579
Endocrine Gland Neoplasms, Endocrine System Diseases
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT00373555
Hemic and Lymphatic Diseases, Hypersensitivity
Calgary, Alberta, Canada
View Trial Details